Not Signed In - ShinNippon Agrees Licensing Nasal Drug Delivery Technology To Tokai Pharmaceuticals
Mon, 07 Aug 2006 06:00 AM EST
... ShinNippon Biomedical Laboratories' two subsidiaries, Translational Research Ltd.(TRL) and Bioactis Ltd. have signed general terms of agreement for the licensing and supplying of their patented nasal drug delivery technology in the field of endocrinology to Tokai Pharmaceuticals of Massachusetts, USA. [click link for full article] ...
Related Topics
- Assistive Technology
- Childbirth
- Health Care Delivery
- Information Systems
- Nasal Cancer
- Drug Safety
- Prescription Drugs
- Ipratropium Nasal
- Mupirocin Nasal
- Drug Side Effects
- Drug Abuse
- Assisted Reproductive Technology
- Drug Information
- Triamcinolone Nasal Inhalation
- Calcitonin Salmon Nasal Spray
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Zolmitriptan Nasal Spray
- Sumatriptan Nasal Spray
- Nicotine nasal spray
email this page
print this page
bookmark this page
feedback on this page
